Charles River Laboratories International, Inc.

Total Valuation

Charles River Laboratories International, Inc. carries a market capitalization of 10.58B, placing it among publicly traded companies globally. Its enterprise value stands at 11.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Charles River Laboratories International, Inc. currently has 48.17M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 2.10, and the price-to-book ratio stands at 6.17.

Enterprise Valuation

On an enterprise value basis, Charles River Laboratories International, Inc. trades at an EV/EBITDA multiple of 14.30 and an EV/FCF ratio of 15.73. The EV/Sales ratio of 2.83 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 25.51 provides insight into valuation relative to core operating earnings.

Financial Position

Charles River Laboratories International, Inc. maintains a current ratio of 1.36, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 102.27, indicating elevated leverage, while an interest coverage ratio of 7.52 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Charles River Laboratories International, Inc. has paid 17.42M in income taxes, reflecting an effective tax rate of 62.51.

Stock Price Statistics

Charles River Laboratories International, Inc.'s stock has gained approximately 46.67201% over the past 52 weeks. The 50-day moving average sits at 191.98, while the 200-day moving average is 184.35.

Income Statement

Over the trailing twelve months, Charles River Laboratories International, Inc. generated 4.03B in revenue and converted that into -184.65M in net income, yielding earnings per share of -3.71. EBITDA reached 796.46M, while operating income came in at 446.36M.

Balance Sheet

Charles River Laboratories International, Inc. holds 191.83M in cash and equivalents against 3.06B in total debt, resulting in a net debt position of 2.47B. Total book value stands at 1.37B, with working capital of 395.10M providing operational flexibility.

Cash Flow

Charles River Laboratories International, Inc. produced 607.03M in operating cash flow over the past twelve months.

Margins

Charles River Laboratories International, Inc. operates with a gross margin of 32.29, reflecting its pricing power and cost economics. The operating margin of 11.08 and net profit margin of -4.59 provide insight into operational efficiency.

Dividends & Yields

Scores

Charles River Laboratories International, Inc. posts an Altman Z-Score of 2.85, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.